SIOP PODC adapted treatment recommendations for standard-risk medulloblastoma in low and middle income settings

Jeannette Parkes, Marc Hendricks, Peter Ssenyonga, John Mugamba, Elizabeth Molyneux, Antoinette Schouten-van Meeteren, Ibrahim Qaddoumi, Graham Fieggen, Sandra Luna-Fineman, Scott Howard, Dipayan Mitra, Eric Bouffet, Alan Davidson, Simon Bailey

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Effective treatment of children with medulloblastoma requires a functioning multi-disciplinary team with adequate neurosurgical, neuroradiological, pathological, radiotherapy and chemotherapy facilities and personnel. In addition the treating centre should have the capacity to effectively screen and manage any tumour and treatment-associated complications. These requirements have made it difficult for many low and middle-income countries (LMIC) centres to offer curative treatment. This article provides management recommendations for children with standard-risk medulloblastoma (localised tumours in children over the age of 3–5 years) according to the level of facilities available. Pediatr Blood Cancer 2015;62:553–564.

Original languageEnglish (US)
Pages (from-to)553-564
Number of pages12
JournalPediatric Blood and Cancer
Volume62
Issue number4
DOIs
StatePublished - Apr 1 2015

Fingerprint

Medulloblastoma
Neoplasms
Radiotherapy
Therapeutics
Drug Therapy

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Parkes, J., Hendricks, M., Ssenyonga, P., Mugamba, J., Molyneux, E., Schouten-van Meeteren, A., ... Bailey, S. (2015). SIOP PODC adapted treatment recommendations for standard-risk medulloblastoma in low and middle income settings. Pediatric Blood and Cancer, 62(4), 553-564. https://doi.org/10.1002/pbc.25313

SIOP PODC adapted treatment recommendations for standard-risk medulloblastoma in low and middle income settings. / Parkes, Jeannette; Hendricks, Marc; Ssenyonga, Peter; Mugamba, John; Molyneux, Elizabeth; Schouten-van Meeteren, Antoinette; Qaddoumi, Ibrahim; Fieggen, Graham; Luna-Fineman, Sandra; Howard, Scott; Mitra, Dipayan; Bouffet, Eric; Davidson, Alan; Bailey, Simon.

In: Pediatric Blood and Cancer, Vol. 62, No. 4, 01.04.2015, p. 553-564.

Research output: Contribution to journalArticle

Parkes, J, Hendricks, M, Ssenyonga, P, Mugamba, J, Molyneux, E, Schouten-van Meeteren, A, Qaddoumi, I, Fieggen, G, Luna-Fineman, S, Howard, S, Mitra, D, Bouffet, E, Davidson, A & Bailey, S 2015, 'SIOP PODC adapted treatment recommendations for standard-risk medulloblastoma in low and middle income settings', Pediatric Blood and Cancer, vol. 62, no. 4, pp. 553-564. https://doi.org/10.1002/pbc.25313
Parkes J, Hendricks M, Ssenyonga P, Mugamba J, Molyneux E, Schouten-van Meeteren A et al. SIOP PODC adapted treatment recommendations for standard-risk medulloblastoma in low and middle income settings. Pediatric Blood and Cancer. 2015 Apr 1;62(4):553-564. https://doi.org/10.1002/pbc.25313
Parkes, Jeannette ; Hendricks, Marc ; Ssenyonga, Peter ; Mugamba, John ; Molyneux, Elizabeth ; Schouten-van Meeteren, Antoinette ; Qaddoumi, Ibrahim ; Fieggen, Graham ; Luna-Fineman, Sandra ; Howard, Scott ; Mitra, Dipayan ; Bouffet, Eric ; Davidson, Alan ; Bailey, Simon. / SIOP PODC adapted treatment recommendations for standard-risk medulloblastoma in low and middle income settings. In: Pediatric Blood and Cancer. 2015 ; Vol. 62, No. 4. pp. 553-564.
@article{cbae2ed52c1c4be0bd397164aa8d64f5,
title = "SIOP PODC adapted treatment recommendations for standard-risk medulloblastoma in low and middle income settings",
abstract = "Effective treatment of children with medulloblastoma requires a functioning multi-disciplinary team with adequate neurosurgical, neuroradiological, pathological, radiotherapy and chemotherapy facilities and personnel. In addition the treating centre should have the capacity to effectively screen and manage any tumour and treatment-associated complications. These requirements have made it difficult for many low and middle-income countries (LMIC) centres to offer curative treatment. This article provides management recommendations for children with standard-risk medulloblastoma (localised tumours in children over the age of 3–5 years) according to the level of facilities available. Pediatr Blood Cancer 2015;62:553–564.",
author = "Jeannette Parkes and Marc Hendricks and Peter Ssenyonga and John Mugamba and Elizabeth Molyneux and {Schouten-van Meeteren}, Antoinette and Ibrahim Qaddoumi and Graham Fieggen and Sandra Luna-Fineman and Scott Howard and Dipayan Mitra and Eric Bouffet and Alan Davidson and Simon Bailey",
year = "2015",
month = "4",
day = "1",
doi = "10.1002/pbc.25313",
language = "English (US)",
volume = "62",
pages = "553--564",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - SIOP PODC adapted treatment recommendations for standard-risk medulloblastoma in low and middle income settings

AU - Parkes, Jeannette

AU - Hendricks, Marc

AU - Ssenyonga, Peter

AU - Mugamba, John

AU - Molyneux, Elizabeth

AU - Schouten-van Meeteren, Antoinette

AU - Qaddoumi, Ibrahim

AU - Fieggen, Graham

AU - Luna-Fineman, Sandra

AU - Howard, Scott

AU - Mitra, Dipayan

AU - Bouffet, Eric

AU - Davidson, Alan

AU - Bailey, Simon

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Effective treatment of children with medulloblastoma requires a functioning multi-disciplinary team with adequate neurosurgical, neuroradiological, pathological, radiotherapy and chemotherapy facilities and personnel. In addition the treating centre should have the capacity to effectively screen and manage any tumour and treatment-associated complications. These requirements have made it difficult for many low and middle-income countries (LMIC) centres to offer curative treatment. This article provides management recommendations for children with standard-risk medulloblastoma (localised tumours in children over the age of 3–5 years) according to the level of facilities available. Pediatr Blood Cancer 2015;62:553–564.

AB - Effective treatment of children with medulloblastoma requires a functioning multi-disciplinary team with adequate neurosurgical, neuroradiological, pathological, radiotherapy and chemotherapy facilities and personnel. In addition the treating centre should have the capacity to effectively screen and manage any tumour and treatment-associated complications. These requirements have made it difficult for many low and middle-income countries (LMIC) centres to offer curative treatment. This article provides management recommendations for children with standard-risk medulloblastoma (localised tumours in children over the age of 3–5 years) according to the level of facilities available. Pediatr Blood Cancer 2015;62:553–564.

UR - http://www.scopus.com/inward/record.url?scp=85007162561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007162561&partnerID=8YFLogxK

U2 - 10.1002/pbc.25313

DO - 10.1002/pbc.25313

M3 - Article

VL - 62

SP - 553

EP - 564

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 4

ER -